Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 30, 2012
Stefan Dürr, Cenduit LLC associate director of project management and an expert in interactive response technology (IRT), will discuss how to avoid the risks of patient or material unblinding when defining drug supply specifications of IRT systems at...
read more
Wednesday, October 31, 2012
Overcoming the challenges of conducting China’s largest outcomes trial and how it relates to doing business in this vital emerging market will be the topic of a joint presentation by Anja Moellman, Senior Project Director for Theorem Clinical ...
read more
Thursday, November 08, 2012
SCYNEXIS, Inc. today announced that the results of a Phase 2a study of lead candidate SCY-635 for the treatment of the hepatitis C virus (HCV) will be the subject of an oral presentation at the 63rd Annual Meeting of the American Association for the ...
read more
Thursday, November 08, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results has selected MetricStream to streamline Audit Management and Corrective Action/Preventive Action (CAPA) ...
read more
Thursday, November 15, 2012
Catalent Pharma Solutions today announced that it had reached a commercial cell line sales agreement with CEVEC Pharmaceuticals for recombinant human alpha-1 antitrypsin (hAAT).
read more
Thursday, November 15, 2012
Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials.
read more
Tuesday, November 27, 2012
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate...
read more
Tuesday, November 27, 2012
Clinical Research Advantage (CRA), the country’s largest community-based network of clinical trial sites, has entered into a strategic agreement with Quintiles to facilitate a higher level of clinical trial participation with an emphasis on safety, ...
read more
Wednesday, December 05, 2012
The European Medicines Agency today published a report highlighting the outcomes of the workshop on access to clinical-trial data and transparency which was hosted at the Agency on 22 November 2012.
read more
Wednesday, December 05, 2012
The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced a preview of its newest intelligence solution, Thomson Reuters Cortellis™ for Clinical Trials ...
read more
Wednesday, December 12, 2012
The Almac Group’s Clinical Technologies business unit is pleased to announce that Charlie Morris has joined the company as Vice President of New Products and Services. In this role, Mr. Morris will report directly to Jim Murphy, President of Almac ...
read more
Friday, December 21, 2012
Merck, known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography (PET) imaging agent...
read more
Thursday, December 27, 2012
PAREXEL International Corporation announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management (RIM) solutions. Liquent ...
read more
Thursday, January 03, 2013
AbbVie today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in January, February, and March. ...
read more